VP of Business Development | LifeSplice Pharma

Directing alternative splicing to conquer disease

LinkedIn
RSS

In Memory of Our Co-Founder Dr. Melanie Tallent NIH Grant Awarded ($670 K) to further Development of Drug to Treat Dravet Syndrome NIH Grant Awarded ($340K) for Initial Drug Development of a Novel Alzheimer’s Disease Treatment. AMPA GluA1-flip targeted oligonucleotide therapy paper published in PLOS One Journal

Home
News
Investors & Partners
- Investor Data
Platform Technology
SMO Advantages
Product Pipeline
Managers
Contact

VP of Business Development

Mr. Michael Christini joins LifeSplice as VP of Business Development and member of Board of Managers

General Inquiries

info@lifesplicepharma.com

© Copyright 2013 by LifeSplice. All Rights Reserved.

Contact